The Greenberg Division of Cardiology, Department of Medicine, Weill Medical College of Cornell University, The New York Presbyterian Hospital, New York, NY 10021, USA.
Eur Heart J. 2010 May;31(10):1212-9. doi: 10.1093/eurheartj/ehq020. Epub 2010 Mar 2.
Early reports indicate a prognostic value of coronary artery disease (CAD) detection by coronary computed tomographic angiography (CCTA), although studies have been limited by small samples in single centres. Coronary computed tomographic angiographic measures of left ventricular ejection fraction (LVEF) to add incremental prognostic value beyond CAD detection have not been examined.
We evaluated 5330 consecutive patients without known CAD undergoing CCTA at two centres. Stenosis severity by CCTA was graded as none (0%), mild (1-49%), moderate (50-69%), or obstructive (> or = 70%). Left ventricular ejection fraction was graded as normal (>50%) or reduced (< or = 50%). About 2.3 +/- 0.6 year follow-up of patients for all-cause mortality was performed using multivariate and Cox proportional hazards models; 100 deaths occurred (1.9%). Detection of obstructive CAD correlated with mortality [hazards ratio (HR) 2.44, 95% confidence interval (CI) 1.61-3.72, P < 0.001]. Compared with those without obstructive CAD, individuals with increasing numbers of vessels with obstructive CAD experienced increased risk of death: 1-vessel (HR 2.23, 95% CI 1.34-3.72), 2-vessel (HR 3.29, 95% CI 1.62-6.71), or 3-vessel (HR 7.35, 95% CI 3.79-14.29) (P < 0.001 for all). Compared with those with LVEF >50%, those with LVEF < or = 50% exhibited higher rates of death (HR 1.56, 95% CI 1.04-2.36, P = 0.03). Annualized mortality rates in those with non-obstructive CAD and LVEF >50% were low (0.51%) and increased accordingly for non-obstructive CAD and LVEF < or = 50% (0.74%), obstructive CAD and LVEF >50% (1.76%), and obstructive CAD and LVEF < or = 50% (3.97%) (log-rank test P < 0.001).
In a large two-centre cohort of patients without known CAD, obstructive CAD detection by CCTA was related to incident death by the absolute presence of as well as increasing numbers of vessels with obstructive CAD. The addition of LVEF by CCTA enhanced risk correlation for death.
早期报告表明,冠状动脉 CT 血管造影(CCTA)检测冠状动脉疾病(CAD)具有预后价值,尽管这些研究受到单中心小样本的限制。CCTA 检测左心室射血分数(LVEF)的测量值是否能增加 CAD 检测之外的预后价值尚未得到检验。
我们在两个中心评估了 5330 例连续无已知 CAD 病史的患者进行 CCTA。CCTA 测量的狭窄严重程度分为无狭窄(0%)、轻度(1-49%)、中度(50-69%)或阻塞性(> = 70%)。LVEF 分为正常(> 50%)或降低(<= 50%)。使用多变量和 Cox 比例风险模型对所有患者进行约 2.3 +/- 0.6 年的全因死亡率随访;100 例死亡(1.9%)。阻塞性 CAD 的检测与死亡率相关[风险比(HR)2.44,95%置信区间(CI)1.61-3.72,P < 0.001]。与无阻塞性 CAD 患者相比,阻塞性 CAD 患者的血管数量越多,死亡风险越高:1 支血管(HR 2.23,95%CI 1.34-3.72),2 支血管(HR 3.29,95%CI 1.62-6.71)或 3 支血管(HR 7.35,95%CI 3.79-14.29)(所有 P < 0.001)。与 LVEF > 50%的患者相比,LVEF <= 50%的患者死亡率更高(HR 1.56,95%CI 1.04-2.36,P = 0.03)。非阻塞性 CAD 且 LVEF > 50%的患者的年死亡率较低(0.51%),而非阻塞性 CAD 且 LVEF <= 50%(0.74%)、阻塞性 CAD 且 LVEF > 50%(1.76%)以及阻塞性 CAD 且 LVEF <= 50%(3.97%)的患者的年死亡率相应增加(log-rank 检验 P < 0.001)。
在一个无已知 CAD 的大型双中心队列中,CCTA 检测到的阻塞性 CAD 与存在和血管数量增加的阻塞性 CAD 患者的死亡事件相关。CCTA 检测 LVEF 增加了死亡风险的相关性。